LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹25 Cr | ₹26 Cr | ₹15 Cr | ₹12 Cr | ₹11 Cr |
What is the latest Total Current Liabilities ratio of LACTOSE (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹25 Cr |
Mar2023 | ₹26 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹12 Cr |
Mar2020 | ₹11 Cr |
How is Total Current Liabilities of LACTOSE (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | -4.04 | |
Mar2023 | ₹26 Cr | 77.51 | |
Mar2022 | ₹15 Cr | 28.26 | |
Mar2021 | ₹12 Cr | 1.93 | |
Mar2020 | ₹11 Cr | - |
Compare Total Current Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹161.3 Cr | -1.3% | 29.9% | -22.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,126.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -1.3% |
29.9% |
-22.2% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses